$BTMD News

B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5

TD Cowen Maintains Buy on Biote, Lowers Price Target to $2

Biote Corp (BTMD) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges and ...

biote Corp. (BTMD) Q2 2026 Earnings Call Transcript

biote Q2 Earnings Call Highlights

Biote FY2026 Revenue expected to be more than $175.000M vs $190.807M Est

Biote Q2 EPS $(0.23) Misses $0.04 Estimate, Sales $44.232M Miss $46.148M Estimate

Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call

How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

Biote Reaffirms FY26 Guidance For Revenue Above $190M And Adjusted EBITDA Above $38M

Biote Appoints CFO And Chief Business Officer Bob Peterson As Interim CEO And Director, Effective June 8; Bret Christensen Steps Down As CEO

biote Corp. Q1 2026 Earnings Call Summary

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Q1 Earnings Call Highlights

Biote Corp (NASDAQ:BTMD) Q1 2026: Revenue Miss Despite EPS Beat

Biote Reports First Quarter 2026 Financial Results

Biote Q1 2026 Earnings Call: Complete Transcript

Biote Q1 EPS $0.06 Beats $0.03 Estimate, Sales $44.935M Miss $46.023M Estimate